Søgeresultater - Michael Kneba
- Showing 1 - 20 results of 50
- Go to Next Page
-
1
-
2
-
3
-
4
Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia af Matthias Ritgen, Alexandra Lange, Stephan Stilgenbauer, Hartmut Döhner, Christian Bretscher, Heidi Bosse, Ariane Stuhr, Michael Kneba, Peter Dreger
Udgivet 2003Artigo -
5
Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome af P. Dreger, Michael A. Rieger, B. Seyfarth, M. Hensel, Michael Kneba, Anthony D. Ho, N. Schmitz, Christiane Pott
Udgivet 2007Artigo -
6
Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia af Dieter Hoelzer, Nicola Gökbuget, W. Digel, Thomas Faak, Michael Kneba, Regina Reutzel, Joanna Romejko‐Jarosińska, Jacek Zwoliński, Jan Walewski
Udgivet 2002Artigo -
7
Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials af Thorsten Raff, Nicola Gökbuget, Silke Lüschen, Regina Reutzel, Matthias Ritgen, Sebastian Irmer, Sebastian Böttcher, Heinz‐August Horst, Michael Kneba, Dieter Hoelzer, Monika Brüggemann
Udgivet 2006Artigo -
8
Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial sta... af Sebastian Böttcher, Matthias Ritgen, Sebastian Buske, Stefan Gesk, W. Klapper, Eva Hoster, Wolfgang Hiddemann, Michael Unterhalt, Martin Dreyling, Reiner Siebert, Michael Kneba, Christiane Pott
Udgivet 2008Artigo -
9
Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis af Sebastian Böttcher, Stephan Stilgenbauer, Robert Busch, Monika Brüggemann, Thorsten Raff, Christiane Pott, Kirsten Fischer, Guenter Fingerle-Rowson, Hartmut Döhner, Michael Hallek, Michael Kneba, Matthias Ritgen
Udgivet 2009Artigo -
10
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of m... af Matthias Ritgen, Stephan Stilgenbauer, Nils von Neuhoff, Andreas Humpe, Monika Brüggemann, Christiane Pott, Thorsten Raff, Alexander Kröber, Donald Bunjes, Richard F. Schlenk, Norbert Schmitz, Hartmut Döhner, Michael Kneba, Peter Dreger
Udgivet 2004Artigo -
11
Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma af Christiane Pott, Carsten Schrader, Stefan Gesk, Lana Harder, Markus Tiemann, Thorsten Raff, Monika Brüggemann, Matthias Ritgen, B. Gahn, Michael Unterhalt, Martin Dreyling, Wolfgang Hiddemann, Reiner Siebert, Peter Dreger, Michael Kneba
Udgivet 2005Artigo -
12
Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkolog... af Peter Thuss‐Patience, Ralf‐Dieter Hofheinz, Dirk Arnold, A. Florschütz, S Daum, Albrecht Kretzschmar, Luisa Mantovani‐Löffler, Dmitry Bichev, Kirstin Breithaupt, Michael Kneba, Guido Schumacher, Matthias Glanemann, Peter Schlattmann, Peter Reichardt, B. Gahn
Udgivet 2012Artigo -
13
Cellular Uptake of Imatinib into Leukemic Cells Is Independent of Human Organic Cation Transporter 1 (OCT1) af Anne T. Nies, Elke Schaeffeler, Heiko van der Kuip, Ingolf Cascorbi, Oliver Bruhn, Michael Kneba, Christiane Pott, Ute Hofmann, Christopher Volk, Shuiying Hu, Sharyn D. Baker, Alex Sparreboom, Peter Ruth, Hermann Koepsell, Matthias Schwab
Udgivet 2013Artigo -
14
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial af Isabelle Krämer, Stephan Stilgenbauer, Sascha Dietrich, Sebastian Böttcher, Matthias Zeis, Michael Stadler, Joerg Thomas Bittenbring, Lutz Uharek, Christof Scheid, Ute Hegenbart, Anthony D. Ho, Michael Hallek, Michael Kneba, Norbert Schmitz, Hartmut Döhner, Peter Dreger
Udgivet 2017Carta -
15
Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies af Nicola Gökbuget, Michael Kneba, Thorsten Raff, Heiko Trautmann, C. R. Bartram, Renate Arnold, Rainer Fietkau, Mathias Freund, Arnold Ganser, Wolfgang Ludwig, Georg Maschmeyer, Harald Rieder, Stefan Schwartz, Hubert Serve, Eckhard Thiel, Monika Brüggemann, Dieter Hoelzer
Udgivet 2012Artigo -
16
Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Rando... af Sebastian Böttcher, Matthias Ritgen, Kirsten Fischer, Stephan Stilgenbauer, Raymonde M. Busch, Günter Fingerle‐Rowson, Anna Maria Fink, Andreas Bühler, Thorsten Zenz, Michael Wenger, Myriam Mendila, Clemens‐Martin Wendtner, Barbara Eichhorst, Hartmut Döhner, Michael Hallek, Michael Kneba
Udgivet 2012Artigo -
17
A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL af Natalie Dimier, Paul Delmar, Carol Ward, Rodica Morariu-Zamfir, Günter Fingerle‐Rowson, Jasmin Bahlo, Kirsten Fischer, Barbara Eichhorst, Valentin Goede, Jacques J. M. van Dongen, Matthias Ritgen, Sebastian Böttcher, Anton W. Langerak, Michael Kneba, Michael Hallek
Udgivet 2017Artigo -
18
Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocy... af Stephan Stilgenbauer, Thorsten Zenz, Dirk Winkler, Andreas Bühler, Richard F Schlenk, Silja Groner, Raymonde Busch, Manfred Hensel, Ulrich Dührsen, Jürgen Finke, Peter Dreger, Ulrich Jäger, Eva Lengfelder, Karin Hohloch, Ulrike Söling, Rudolf Schlag, Michael Kneba, Michael Hallek, Hartmut Döhner
Udgivet 2009Artigo -
19
First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial af Anton Hagenbeek, Ole Gadeberg, Peter Johnson, Lars Møller Pedersen, Jan Walewski, Andrzej Hellmann, Brian K. Link, Tadeusz Robak, Marek Z. Wojtukiewicz, Michael Pfreundschuh, Michael Kneba, Andreas Engert, Pieter Sonneveld, Mimi Folden Flensburg, Jørgen Holm Petersen, Nedjad Losic, John Radford
Udgivet 2008Artigo -
20
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology af Jann Arends, G. Bodoky, Federico Bozzetti, Kenneth C.H. Fearon, Maurizio Muscaritoli, Guntars Selga, M.A.E. de van der Schueren, Maarten von Meyenfeldt, G. Zürcher, Rainer Fietkau, E. Aulbert, Barbara Frick, Matilda Holm, Michael Kneba, H. J. Mestrom, A. Zander
Udgivet 2006Artigo
Søgeredskaber:
Relaterede emner
Medicine
Internal medicine
Oncology
Leukemia
Immunology
Biology
Chemotherapy
Genetics
Lymphoma
Gastroenterology
Gene
Minimal residual disease
Chronic lymphocytic leukemia
Rituximab
Surgery
Transplantation
Cyclophosphamide
Cancer research
Cancer
Clinical trial
Myeloid leukemia
Adverse effect
Fludarabine
Regimen
Antibody
Autologous stem-cell transplantation
Clinical endpoint
Gene expression
Imatinib
Immune system